292 related articles for article (PubMed ID: 26577510)
1. Thalidomide for the treatment of chronic refractory pruritus.
Sharma D; Kwatra SG
J Am Acad Dermatol; 2016 Feb; 74(2):363-9. PubMed ID: 26577510
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide for the treatment of chronic refractory prurigo nodularis.
Aguh C; Kwatra SG; He A; Okoye GA
Dermatol Online J; 2018 Mar; 24(3):. PubMed ID: 29634881
[TBL] [Abstract][Full Text] [Related]
3. Antipruritic action of thalidomide.
Daly BM; Shuster S
Acta Derm Venereol; 2000; 80(1):24-5. PubMed ID: 10721827
[TBL] [Abstract][Full Text] [Related]
4. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Phan NQ; Bernhard JD; Luger TA; Ständer S
J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
[TBL] [Abstract][Full Text] [Related]
5. Prurigo nodularis: a review.
Lee MR; Shumack S
Australas J Dermatol; 2005 Nov; 46(4):211-18; quiz 219-20. PubMed ID: 16197418
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of evidence-based treatments for prurigo nodularis.
Qureshi AA; Abate LE; Yosipovitch G; Friedman AJ
J Am Acad Dermatol; 2019 Mar; 80(3):756-764. PubMed ID: 30261199
[TBL] [Abstract][Full Text] [Related]
7. Use of lenalidomide in treating refractory prurigo nodularis.
Liu H; Gaspari AA; Schleichert R
J Drugs Dermatol; 2013 Mar; 12(3):360-1. PubMed ID: 23545923
[TBL] [Abstract][Full Text] [Related]
8. Aprepitant for the Treatment of Chronic Refractory Pruritus.
He A; Alhariri JM; Sweren RJ; Kwatra MM; Kwatra SG
Biomed Res Int; 2017; 2017():4790810. PubMed ID: 29057261
[TBL] [Abstract][Full Text] [Related]
9. Treatment of prurigo nodularis with lenalidomide.
Ossorio-García L; Jiménez-Gallo D; Rodríguez-Mateos ME; Arjona-Aguilera C; Linares-Barrios M
Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27891738
[TBL] [Abstract][Full Text] [Related]
10. A review of thalidomide's history and current dermatological applications.
Perri AJ; Hsu S
Dermatol Online J; 2003 Aug; 9(3):5. PubMed ID: 12952752
[TBL] [Abstract][Full Text] [Related]
11. Innovative uses of thalidomide.
Chen M; Doherty SD; Hsu S
Dermatol Clin; 2010 Jul; 28(3):577-86. PubMed ID: 20510766
[TBL] [Abstract][Full Text] [Related]
12. Dermatologic and nondermatologic uses of thalidomide.
Nasca MR; Micali G; Cheigh NH; West LE; West DP
Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy.
Maurer T; Poncelet A; Berger T
Arch Dermatol; 2004 Jul; 140(7):845-9. PubMed ID: 15262695
[TBL] [Abstract][Full Text] [Related]
14. Prurigo nodularis of Hyde treated with low-dose thalidomide.
Orlando A; Renna S; Cottone M
Eur Rev Med Pharmacol Sci; 2009; 13(2):141-5. PubMed ID: 19499850
[TBL] [Abstract][Full Text] [Related]
15. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study.
Duque MI; Yosipovitch G; Fleischer AB; Willard J; Freedman BI
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):519-21. PubMed ID: 15761435
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide in 42 patients with prurigo nodularis Hyde.
Andersen TP; Fogh K
Dermatology; 2011; 223(2):107-12. PubMed ID: 21952556
[TBL] [Abstract][Full Text] [Related]
17. Non-Atopic Chronic Nodular Prurigo (Prurigo Nodularis Hyde): A Systematic Review of Best-Evidenced Treatment Options.
Frølunde AS; Wiis MAK; Ben Abdallah H; Elsgaard S; Danielsen AK; Deleuran M; Vestergaard C
Dermatology; 2022; 238(5):950-960. PubMed ID: 35417906
[TBL] [Abstract][Full Text] [Related]
18. Role of Pregabalin in Management of Pruritus: A Literature Review.
Foroutan N; Nikvarz N
J Pharm Pharm Sci; 2016; 19(4):465-474. PubMed ID: 28057164
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide and its impact in dermatology.
Stirling DI
Semin Cutan Med Surg; 1998 Dec; 17(4):231-42. PubMed ID: 9859910
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms.
Domingo S; Solé C; Moliné T; Ferrer B; Ordi-Ros J; Cortés-Hernández J
Dermatology; 2020; 236(5):467-476. PubMed ID: 32659758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
